Skip to main content
AIRS logo

AIRS · Airsculpt Technologies, Inc.

Track AIRS — free
$2.74 +0.07 (+2.62%) At close · Aug 21
Market Cap
$197.54M
Shares
72.10M

Price & Indicators

20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$2.74 Open$2.71 Day$2.66–2.84 52W close$1.58–11.65 Avg vol 30d765K Short int2.8M · 3.8% float · 6.9d Short vol38% Last earningsAug 10, 2026 DataOct 2021–Aug 2026 Filing10-Q · Aug 10

Up next

Next earnings call
Nov 14, 2026 Est · unconfirmed · in 12 wks
FQ3-26 quarter ends
~Sep 30, 2026 Est
filed Aug 10, 2026

AI Brief

TL;DR.

Bullish
    Bearish

      AI-generated from the earnings call and 8-K · may contain errors · not investment advice

      Ask ALVIS about this →

      Equibles Rating

      blended score · not investment advice
      Overall
      Sell
      SellHoldBuy
      Technical Strong Sell Momentum Strong Sentiment Bullish Fundamentals Weak Quant / Vol Very High
      Market backdrop VIX 15.1 · calm Equity put/call 0.51
      Technical
      price trend
      Strong Sell
      50 / 200-day cross No cross
      Price vs 200-day avg −22%
      below
      Price vs 50-day avg −37%
      below
      RSI (14) 33
      neutral
      MACD trend Negative
      52-week position 12%
      near low
      Momentum
      relative strength
      Strong
      1-month return −41%
      trailing
      6-month return +60%
      trailing
      YTD return +38%
      this year
      Relative strength +49%
      vs S&P · 6-mo
      Sentiment
      smart money
      Bullish
      Trend (MA cross) No cross
      50d $4 › 200d $4 — 50d above 200d
      Institutional flow Accumulating
      +14% holders QoQ · +26 funds added
      Insider flow Flat
      No net insider activity over 90 days
      Short interest Falling
      3.83% of float · ▼ -10.6% MoM · 6.9 days cover
      Volume signal Normal
      Volume near normal
      Institution breadth Multi-yr high
      103 holders — near 3-yr high, broad support
      Squeeze score 57
      elevated · 0–100
      Fundamentals
      Weak
      Revenue growth −16%
      Y/Y
      EPS growth −36%
      Y/Y
      Free cash flow $692.0K
      Balance sheet $47.6M
      net debt
      Quant / Vol
      risk profile
      Very High
      Volatility 128%
      annualized · 1-yr
      Max drawdown −86%
      past year
      ATR 14.5%
      of price · 14-day

      Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

      Guidance & track record

      Beat or met 1 of last 3
      Latest guidance · from the 8-K filed Aug 10, 2026
      Revenue · full year 2026 Initiated $151M – $157M
      prior FY $151.82M midpoint +1.4% Y/Y
      Adjusted EBITDA · full year 2026 Non-GAAP Initiated $12M – $14M
      Prior guidance period ended · from the 8-K filed Apr 2, 2026
      Revenue · first quarter 2026 $38.5M – $39.5M
      Guided vs delivered · last 3 settled
      Revenues full year 2025
      guided $153M
      $151.82M Miss −0.8%
      Revenue 2024
      guided $220M
      $180.35M Miss −18.0%
      Revenue 2023
      guided $187M – $192M
      $195.92M Beat +3.4%

      Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

      Technicals

      trend & momentum for long-term holders Strong Sell
      4 · 2 · 0
      50 / 200-day cross
      No cross Neutral
      Price vs 200-day avg
      −22% Bearish
      Price vs 50-day avg
      −37% Bearish
      RSI (14)
      33 Neutral
      MACD trend
      Negative Bearish
      52-week position
      12% Bearish
      Market signals — smart money & positioning
      Bullish · 3 of 6
      Trend (MA cross) No cross
      50d $4 › 200d $4 — 50d above 200d
      Institutional flow Accumulating
      +14% holders QoQ · +26 funds added
      Insider flow Flat
      No net insider activity over 90 days
      Short interest Falling
      3.83% of float · ▼ -10.6% MoM · 6.9 days cover
      Volume signal Normal
      Volume near normal
      Institution breadth Multi-yr high
      103 holders — near 3-yr high, broad support
      Price context
      position in its 52-week range
      Range low $2 Now $3 · 12% Range high $12
      vs 200-day avg -22% vs 50-day avg -37%

      Illustrative technical + ownership context — a signal mix, not investment advice.

      Key metrics

      the company's own KPIs, from written earnings releases and filings
      Metric Latest Period YoY
      Adjusted net (loss)/income non-GAAP -$211K Six Months Ended June 30, 2026
      Adjusted net loss per share of common stock non-GAAP $0 Six Months Ended June 30, 2026
      Case growth -0.5% Three Months Ended June 30, 2026 filing
      Customer acquisition costs per customer $3,467 the three months ended June 30, 2026 filing
      Number of facilities 31 Six Months Ended June 30, 2026
      Revenue per case growth -2.1% Three Months Ended June 30, 2026 filing
      Same-center revenue per case growth -2% Q2 2026
      Adjusted net loss non-GAAP -$821K Three Months Ended March 31, 2026
      Adjusted Net Loss per Share non-GAAP -$0.01 Three Months Ended March 31, 2026
      Same-center Number of total procedure rooms 65 Three Months Ended March 31, 2026
      same-store revenue -16% Q4 2025

      Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period

      Versus peers

      Medical Care Facilities — same industry group
      Open screener →
      Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
      AIRS
      Airsculpt Technologies, Inc.
      this stock
      $197.54M +38.4% -15.8% 3.8%
      HCA
      HCA Healthcare, Inc.
      $95.21B -8.1% +7.1% 14.8 2.7%
      FSNUY
      Fresenius SE & Co. KGaA
      $30.73B -4.8% 0.0%
      THC
      Tenet Healthcare Corp
      $22.61B +41.3% +0.9% 10.8 4.0%
      FMS
      Fresenius Medical Care AG
      $12.47B -1.6% +5.9% 0.5%

      Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

      At a glance

      key data from every section
      Ownership
      Institutional Holders Accumulating
      Holders
      103
      % held
      64.0%
      Net QoQ
      +3.9M sh
      Top holder
      Vesey Street Capital Part…
      Held Float
      View
      Held by Funds
      Fund positions
      82
      View
      Short & Settlement
      Short Interest Falling
      Shares short
      2.8M
      Days to cover
      6.9d
      Change
      -327.9K sh
      View
      Short Volume
      Short vol %
      38%
      As of
      Aug 21, 2026
      Short Total
      View
      Fails to Deliver
      FTD shares
      999
      Value
      $4.8K
      As of
      Jul 31, 2026
      View
      Off-Exchange
      Off-exchange %
      44.2%
      Week of
      Jul 13, 2026
      Off-exch Lit
      View
      Financials
      Financials
      Revenue (FY)
      $151.8M
      Net income (FY)
      $-11.7M
      EPS diluted
      $-0.19
      View
      Filings
      SEC Filings
      Latest
      8-K
      Filed
      Aug 12, 2026
      This year
      15
      View
      Proposed Sales
      Value
      $16.7K
      Shares
      2.6K
      Filed
      Nov 15, 2024
      View
      Earnings & Events
      Earnings Calls
      Last call
      Aug 11, 2026
      View

      Performance

      5D 20D 120D MTD YTD
      AIRS -20.1% -40.6% +60.2% -43.0% +38.4%
      SPY -1.4% +3.6% +11.6% +2.5% +12.3%
      vs SPY -18.8% -44.2% +48.7% -45.5% +26.1%

      Capital returns

      Latest dividend
      $0.41 / share · ex Aug 25, 2022
      Paid (TTM)
      $0.00 / share · 0 payouts
      Dividend yield (TTM, derived)
      · no payout in the trailing year

      Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

      Key facts CIK 1870940 CUSIP 009496100 13F (30d) 95 filings 94 filers Visit website Investor relations